Monday
SESSION 2: TREATING HCC
SESSION 2 SCHEDULE
10:10 AM - 10:20 AM Surgery: Indications, Contraindications, Techniques That Can Expand The Role Of Surgery
  Presenter(s):Milan Kinkhabwala, MD  
  View Slides in PDF      
10:20 AM - 10:30 AM Ultrasound Contrast May Improve US Guided Ablation Of Small Lesions
  Presenter(s):Uei Pua, FRCR  
  View Slides in PDF      
10:30 AM - 10:40 AM The Data Suggests Y-90 Is As Good As TACE/Ablate For HCC Less Than 5 cm
  Presenter(s):Riad Salem, MD, MBA  
  View Slides in PDF      
10:40 AM - 10:50 AM TACE/Ablate Remains The Standard For HCC Less Than 5 cm
  Presenter(s):Jean Francois H. Geschwind, MD  
  View Slides in PDF      
10:50 AM - 11:00 AM Technology And Techniques To Adequately Embolize Inaccessible Small Vessels Feeding Tumors
  Presenter(s):David C. Madoff, MD  
  View Slides in PDF      
11:00 AM - 11:10 AM Cone Beam CT: Interventional Oncology Should Not Be Practiced Without It
  Presenter(s):Edward Kim, MD  
  View Slides in PDF      
11:10 AM - 11:20 AM Value Of Radiopaque Beads: Early Clinical Applications
  Presenter(s):Bradford Wood, MD  
  View Slides in PDF      
11:20 AM - 11:30 AM New Technology To Target And Assess Adequacy Of Ablation
  Presenter(s):Kevin Kim, MD  
  View Slides in PDF      
11:30 AM - 11:40 AM Portal Vein Embolization To Increase Size Of Future Liver Remnant In Cirrhotics: Should The Hepatoma Be Embolized Prior To PVE
  Presenter(s):David C. Madoff, MD  
  View Slides in PDF      
11:40 AM - 11:50 AM Radioembolization Can Replace PVE To Increase The FLR In Many Cases
  Presenter(s):Riad Salem, MD, MBA  
  View Slides in PDF      
11:50 AM - 12:00 PM Panel Discussion
12:00 PM - 12:10 PM Break – Pick up lunch in South Corridor Exhibit Area (2nd Floor) and return to Murray Hill Suites for Luncheon Program.
END OF SESSION 2
previous next